EyeGene Inc. (KOSDAQ:185490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,327.00
0.00 (0.00%)
At close: Feb 19, 2026

EyeGene Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,9331,4255,4962,0462,6492,723
Short-Term Investments
23,12231,12249,87259,08072,68029,158
Trading Asset Securities
194.37--5,32910,027468.34
Cash & Short-Term Investments
26,24932,54755,36866,45585,35732,349
Cash Growth
-24.71%-41.22%-16.68%-22.14%163.86%-18.10%
Accounts Receivable
1,0161,415468.06898.07731.32841.91
Other Receivables
-312.04428.64486.97296.149.91
Receivables
1,0161,727896.71,3851,027891.82
Inventory
466.56584.9955.21498.01774.4704.49
Prepaid Expenses
-149.19240.5---
Other Current Assets
265.52289.3317.01492.771,4852,172
Total Current Assets
27,99735,29856,87768,83088,64436,117
Property, Plant & Equipment
6,5199,3159,8515,7425,8643,549
Long-Term Investments
14,40414,1599,3373,8074,0761,136
Other Intangible Assets
4,8244,281982.61844.1761.27487.42
Other Long-Term Assets
2,8602,1501,0551,1585,6463,137
Total Assets
56,60465,30678,10380,381104,99144,427
Accounts Payable
1,1561,680470.69863.841,8941,530
Accrued Expenses
-252.29341.29343.29361.4378.66
Short-Term Debt
-1,7731,4981,3922,9955,234
Current Portion of Leases
173.52179.6314.49392.85272.63228.49
Current Unearned Revenue
-0.643.333.23.1664.74
Other Current Liabilities
5,6375,5345,6341,9244,0831,353
Total Current Liabilities
6,9669,4198,2624,9209,6098,489
Long-Term Debt
-----11,516
Long-Term Leases
424.05487.56338.43611.41676.06144.1
Pension & Post-Retirement Benefits
2,7742,5463,4854,6134,0552,411
Long-Term Deferred Tax Liabilities
----1,1681,252
Other Long-Term Liabilities
562.28437.83626.991,281513.647,716
Total Liabilities
10,72712,89112,71311,42616,02231,528
Common Stock
13,51513,51513,51510,73910,7055,825
Additional Paid-In Capital
188,319188,325188,329176,131176,27770,688
Retained Earnings
-168,611-161,740-149,862-129,722-103,829-68,053
Comprehensive Income & Other
10,49710,22111,2489,5805,8164,440
Total Common Equity
43,72050,32163,23066,72888,96912,899
Minority Interest
335.72513.521,1042,228--
Shareholders' Equity
45,87752,41565,39068,95688,96912,899
Total Liabilities & Equity
56,60465,30678,10380,381104,99144,427
Total Debt
597.572,4412,1512,3973,94317,122
Net Cash (Debt)
25,65130,10753,21764,05881,41315,228
Net Cash Growth
-17.05%-43.43%-16.92%-21.32%434.64%-28.51%
Net Cash Per Share
815.701113.842458.552987.224298.371101.24
Filing Date Shares Outstanding
27.0227.0327.0321.4821.4113.98
Total Common Shares Outstanding
27.0227.0327.0321.4821.4113.98
Working Capital
21,03125,87848,61563,91179,03427,629
Book Value Per Share
1617.891861.692339.283106.774155.60922.76
Tangible Book Value
38,89646,04062,24865,88488,20812,412
Tangible Book Value Per Share
1439.371703.312302.933067.474120.04887.90
Machinery
-13,37413,3927,2516,1544,418
Construction In Progress
---102.83613.25-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.